Discovery and ADMET: Where Are We Now (English)
- New search for: A. Smith, Dennis
- New search for: A. Smith, Dennis
In:
Current Topics in Medicinal Chemistry
;
11
, 4
;
467-481
;
2011
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Discovery and ADMET: Where Are We Now
-
Additional title:CTMC
-
Contributors:A. Smith, Dennis ( author )
-
Published in:Current Topics in Medicinal Chemistry ; 11, 4 ; 467-481
-
Publisher:
- New search for: Bentham Science Publishers Ltd.
-
Publication date:2011-04-01
-
Size:15 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 11, Issue 4
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 331
-
Editorial [Hot topic: Drug Design from the ADME/PK Perspective: Does Chemical Intuition Suffice in Multifaceted Drug Discovery? (Guest Editors: Franco Lombardo & Nigel J. Waters)]Lombardo, F. / J. Waters, Nigel et al. | 2011
- 334
-
Predicting Clearance in Humans from In Vitro DataScott Obach, R. et al. | 2011
- 340
-
Controversies in Allometric Scaling for Predicting Human Drug Clearance: An Historical Problem and Reflections on What Works and What Does NotTang, Huadong / Mayersohn, Michael et al. | 2011
- 351
-
Drug Design Tools - In Silico, In Vitro and In Vivo ADME/PK Prediction and Interpretation: Is PK in Monkey An Essential Part of a Good Human PK Prediction?A. Hosea, Natilie et al. | 2011
- 358
-
In-Silico ADME Models: A General Assessment of their Utility in Drug Discovery ApplicationsPaul Gleeson, M. / Hersey, Anne / Hannongbua, Supa et al. | 2011
- 382
-
Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and DevelopmentO. Nettleton, David / J. Einolf, Heidi et al. | 2011
- 404
-
Pharmacodynamic-Pharmacokinetic Integration as a Guide to Medicinal ChemistryGabrielsson, Johan / Fjellstrom, Ola / Ulander, Johan / Rowley, Michael / H. Van Der Graaf, Piet et al. | 2011
- 419
-
Strategies and Chemical Design Approaches to Reduce the Potential for Formation of Reactive Metabolic SpeciesA. Argikar, Upendra / B. Mangold, James / P. Harriman, Shawn et al. | 2011
- 450
-
Do We Need to Optimize Plasma Protein and Tissue Binding in Drug Discovery?Liu, Xingrong / Chen, Cuiping / E.C.A. Hop, Cornelis et al. | 2011
- 467
-
Discovery and ADMET: Where Are We NowA. Smith, Dennis et al. | 2011